These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 374166)

  • 1. Preliminary experience with controlled-release aminophylline in asthmatic children: salivary levels and peak flow following a single dose.
    Evans N; Evans PW; Boobis SW
    J Int Med Res; 1979; 7 Suppl 1():93-7. PubMed ID: 374166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
    McKenzie S; Baillie E
    J Int Med Res; 1979; 7 Suppl 1():22-7. PubMed ID: 437305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective and objective changes noted by patients with bronchial asthma taking slow-release aminophylline.
    Nicholson EM; Laszlo G
    J Int Med Res; 1979; 7 Suppl 1():32-3. PubMed ID: 374161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
    Branica S; Vrabec B; Francetić I; Bakran I
    Lijec Vjesn; 1989; 111(9-10):341-3. PubMed ID: 2633012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
    Longo G; Poli F; Strinati R; Longo F
    Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
    Schaefers M; Richter O; Reinhardt D; Becker B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
    Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of slow-release oral aminophylline on circadian variation in airflow obstruction in asthmatics.
    Cole RB; Al-Khader A
    J Int Med Res; 1979; 7 Suppl 1():40-4. PubMed ID: 374163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive interaction of aminophylline and salbutamol in asthma: an in vivo study using dose-response curves.
    Leopold D; Handslip P
    J Int Med Res; 1979; 7 Suppl 1():52-5. PubMed ID: 374165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and predictive value of salivary theophylline levels.
    Jaber M; Schneider AT; Goldstein S; Sergiou H; Bjornson L; Chiaramonte LT
    Ann Allergy; 1987 Feb; 58(2):105-8. PubMed ID: 3813126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of slow-release salbutamol with slow-release aminophylline in nocturnal asthma.
    Milledge JS; Morris J
    J Int Med Res; 1979; 7 Suppl 1():106-10. PubMed ID: 35430
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaproterenol sulfate for asthmatic children with therapeutic serum theophylline concentrations.
    Kelly HW; Menendez R; Murphy S; Tuttle W
    Clin Pharm; 1982; 1(1):49-54. PubMed ID: 6764162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminophylline, salbutamol and combined intravenous infusions in acute severe asthma.
    Evans WV; Monie RD; Crimmins J; Seaton A
    Br J Dis Chest; 1980 Oct; 74(4):385-9. PubMed ID: 7011354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two aminophylline preparations in nocturnal asthma.
    Al-Khader A; Cole RB; Thompson D
    Br J Dis Chest; 1979 Apr; 73(2):169-72. PubMed ID: 394755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of choline theophyllinate (Choledyl) and controlled release aminophylline (Phyllocontin).
    Maneksha S
    Br J Clin Pract; 1978 Feb; 32(2):52-5. PubMed ID: 666955
    [No Abstract]   [Full Text] [Related]  

  • 18. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
    Tal A; Aviram M; Gorodischer R
    J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of slow-release aminophylline in childhood asthma: are short-term trials valid?
    Wilson N; Silverman M
    Br Med J (Clin Res Ed); 1982 Mar; 284(6319):863-6. PubMed ID: 6802327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.